AzTrials
AzTrials

Research institution

Second Affiliated Hospital, Zhejiang University, School of Medicine Clinical Trials

Studies where Second Affiliated Hospital, Zhejiang University, School of Medicine is the lead sponsor: what is enrolling now, by phase, condition and country.

1,145 registered studies

In numbers

Open to volunteers
448
Active
486
With results posted
4
All registered
1,145

Open to volunteers: recruiting, not yet recruiting or enrolling by invitation. Active adds studies under way that have stopped recruiting.

Open to volunteers

All 448
  • Critically Ill Patients Requiring Mechanical Ventilation

    Development and Preliminary Validation of Intelligent Video Laryngoscope for Emergency Use

    • Recruiting
    • Age: 18 years and older
    • Medical device

    The investigators are developing a video laryngoscope equipped with artificial intelligence technology to enable automatic identification of key airway anatomical structures and real-time guidance during intubation, with the aim…

    Trial name
    MEASURE-ILD (NCT07922044)
    Testing
    AI-video laryngoscopy (AIVL), Conventional Video Laryngoscope (VL)
    Where
    2 sites in China
    Volunteers
    120 people
    Sponsor
    Second Affiliated Hospital, Zhejiang University, School of Medicine
  • Traumatic Brain Injury

    the Safety and the Efficiency of Hyperbaric Oxygen in Traumatic Brain Injury

    • Recruiting
    • Age: 18 to 90 years
    • Observational study

    The goal of this observational study is to learn about the safety and long-term effects of hyperbaric oxygen therapy in participants over the age of 18 with traumatic brain injury (TBI).

    Trial name
    NCT06816199
    Testing
    Hyperbaric oxygen exposure
    Where
    China
    Volunteers
    300 people
    Sponsor
    Second Affiliated Hospital, Zhejiang University, School of Medicine
  • Otitis Media With Effusion (OME)

    Short-term Application of Lactoferrin Ventilation Tubes

    • Not yet recruiting
    • Age: 18 to 65 years
    • Medical device

    This study aims to evaluate the feasibility and preliminary biocompatibility of a novel lactoferrin-based ventilation tube and its manufacturing process for use in implantable medical materials.

    Trial name
    ST-LVT (NCT07913490)
    Testing
    Ventilation tube insertion
    Volunteers
    20 people
    Sponsor
    Second Affiliated Hospital, Zhejiang University, School of Medicine
    Can I take part? ST-LVT
  • Anxiety Disorders, Depressive Disorder

    A Prospective Study of Anxiety, Depression, and Bipolar Disorder in People

    • Recruiting
    • Age: 12 to 55 years
    • Observational study

    This study aims to understand how anxiety disorders, depressive disorders, and bipolar disorder change over time and to identify patterns that may help with earlier recognition, diagnosis, and prediction of future symptoms.

    Conditions
    Anxiety Disorders, Depressive Disorder, Bipolar Disorder (BD)
    Trial name
    NCT07903246
    Where
    China
    Volunteers
    2,690 people, healthy volunteers welcome
    Sponsor
    Second Affiliated Hospital, Zhejiang University, School of Medicine
    Can I take part? NCT07903246
  • Octogenarian Patients With Non-metastatic Resectable Colorectal Cancer

    SGA-OCRC: Prediction of 90-Day Major Adverse Postoperative Outcomes in Octogenarians With Resectable Colorectal Cancer

    • Not yet recruiting
    • Age: 80 years and older
    • Observational study

    Octogenarian patients with colorectal cancer are a growing population with substantial heterogeneity in frailty, functional reserve, nutritional status, and comorbidity.

    Trial name
    NCT07903129
    Volunteers
    1,000 people
    Sponsor
    Second Affiliated Hospital, Zhejiang University, School of Medicine
    Can I take part? NCT07903129
  • Acute Ischemic Stroke

    Recombinant Human Prourokinase for Acute Ischemic Stroke in the Extended Window Selected by CT-Based Artificial Intelligence

    • Not yet recruiting
    • Age: 18 years and older
    • Phase 3
    • Injection or infusion

    This multicenter, prospective, randomized, double-blind, placebo-controlled trial aims to evaluate the efficacy and safety of intravenous recombinant human prourokinase (rhPro-UK) in patients with acute ischemic stroke treated…

    Trial name
    RAISE-AI (NCT07901842)
    Testing
    Recombinant Human Prourokinase for Injection (rhPro-UK)
    Where
    China
    Volunteers
    826 people
    Sponsor
    Second Affiliated Hospital, Zhejiang University, School of Medicine
    Can I take part? RAISE-AI
  • Acute Ischemic Stroke

    Stimulation-Temperature-Oxygen-Positioning Multimodal Neuroprotection for Acute Ischemic Stroke (STOP)

    • Not yet recruiting
    • Age: 18 years and older

    Acute ischemic stroke may result in substantial disability despite timely reperfusion therapy because ischemic and reperfusion-related brain injury can continue before, during, and after restoration of blood flow.

    Trial name
    STOP (NCT07840794)
    Testing
    Stimulation-Temperature-Oxygen-Positioning (STOP) Multimodal Neuroprotective Strategy, Guideline-Based Reperfusion Therapy and Standard Stroke-Unit Care
    Volunteers
    380 people
    Sponsor
    Second Affiliated Hospital, Zhejiang University, School of Medicine
    Can I take part? STOP
  • Invasive Breast Cancer

    Adding Preoperative Radiotherapy Based on Early Treatment Response in Breast Cancer

    • Not yet recruiting
    • Age: 18 to 75 years
    • Phase 2
    • Surgery or procedure

    RAPID-NeoBC is a prospective, multicentre, response-adapted study with a randomized component for adults with operable, nonmetastatic invasive breast cancer receiving guideline-recommended neoadjuvant systemic therapy.

    Trial name
    RAPID-NeoBC (NCT07892508)
    Testing
    Response-adapted preoperative radiotherapy, Guideline-recommended neoadjuvant systemic therapy, Serial contrast-enhanced breast MRI and breast-specific gamma imaging
    Where
    2 sites in China
    Volunteers
    200 people
    Sponsor
    Second Affiliated Hospital, Zhejiang University, School of Medicine
    Can I take part? RAPID-NeoBC
  • Atrial Fibrillation (AF)

    Energy Dose and Cardioversion Outcomes in AF

    • Not yet recruiting
    • Age: 18 to 80 years

    This multicenter, randomized study will compare two electrical cardioversion energy strategies in adults with atrial fibrillation who are scheduled to undergo cardioversion during atrial fibrillation ablation or within 3 months…

    Trial name
    LE-HI-CV (NCT07884253)
    Testing
    Synchronized Electrical Cardioversion With Different Energy Strategies, Conventional Step-Up Energy Cardioversion
    Volunteers
    400 people, healthy volunteers welcome
    Sponsor
    Second Affiliated Hospital, Zhejiang University, School of Medicine
    Can I take part? LE-HI-CV
  • Intracerebral Hemorrhage, Atrial Fibrillation (AF)

    Oral Anticoagulation in Patients With Prior Deep Intracerebral Hemorrhage, Atrial Fibrillation, and Ischemic Stroke

    • Not yet recruiting
    • Age: 18 years and older
    • Phase 4
    • Pill or oral medicine

    This prospective, multicenter, randomized, open-label, blinded-endpoint trial aims to evaluate the efficacy and safety of oral anticoagulation with apixaban in patients with non-valvular atrial fibrillation, ischemic stroke, and…

    Conditions
    Intracerebral Hemorrhage, Atrial Fibrillation (AF), Ischemia Stroke
    Trial name
    OASIS-AF (NCT07609654)
    Testing
    Apixaban, No Oral Anticoagulation Strategy
    Where
    China
    Volunteers
    852 people
    Sponsor
    Second Affiliated Hospital, Zhejiang University, School of Medicine
    Can I take part? OASIS-AF

Completed, with results posted

All 4
  • Parkinson Disease

    Efficacy and Safety of TJ0113 Capsule in Patients With Parkinson's Disease

    • Completed
    • Age: 30 to 80 years
    • Phase 2
    • Results posted

    A randomized, double-blind, placebo parallel-controlled Phase II clinical trial to evaluate the efficacy and safety of TJ0113 capsule in patients with early-stage Parkinson's disease

    Trial name
    NCT06596005
    Testing
    TJ0113 200mg, TJ0113 400mg
    Where
    China
    Volunteers
    149 people
    Sponsor
    Second Affiliated Hospital, Zhejiang University, School of Medicine
    Can I take part? NCT06596005
  • Malocclusion

    Comparing of the Clinical Outcome of Periodontal Accelerated Osteogenic Orthodontics With Horizontal or Vertical Releasing Incisions

    • Completed
    • Age: 18 to 40 years
    • Surgery or procedure
    • Results posted

    The study aims to compare the effect of periodontal accelerated osteogenic orthodontics (PAOO) with horizontal or vertical releasing incisions on operation time, healing, adverse effects, and effectiveness of bone augmentation.

    Trial name
    NCT05441683
    Testing
    horizontal extending incision, vertical releasing incision
    Where
    China
    Volunteers
    22 people
    Sponsor
    Second Affiliated Hospital, Zhejiang University, School of Medicine
    Can I take part? NCT05441683
  • Nutrition, Enteral

    A More Physiological Feeding Process in ICU:the Intermittent Infusion With Semi-solidification of Nutrients

    • Completed
    • Age: 14 to 90 years
    • Results posted

    Malnutrition and underfeeding are major challenges in caring for critically ill patients. Continuous feeding were thought to be better tolerated by patients with the limited absorptive gut surface area or gastrointestinal…

    Trial name
    NCT03017079
    Testing
    semi-solid agent with standard enteral feeding, standard enteral feeding
    Where
    China
    Volunteers
    40 people
    Sponsor
    Second Affiliated Hospital, Zhejiang University, School of Medicine
  • Lymphoma, Large B-Cell, Diffuse

    18F-FDG PET Radiomics of Diffuse Large B-cell Lymphoma

    • Completed
    • Age: 18 years and older
    • Observational study
    • Results posted

    This study aims to investigate the prognostic value of 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET) radiomics in diffuse large B-cell lymphoma (DLBCL) and its additional value to the International…

    Trial name
    NCT04317313
    Testing
    FDG PET radiomic feature evaluation
    Where
    China
    Volunteers
    152 people
    Sponsor
    Second Affiliated Hospital, Zhejiang University, School of Medicine
    Can I take part? NCT04317313

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in